Lisa Wilmes, PhD
Specialist
Radiology
School of Medicine

Publications (49)

Top publication keywords:
BreastDiffusion Magnetic Resonance ImagingBreast NeoplasmsMagnetic Resonance ImagingTaxoidsImage EnhancementBridged-Ring CompoundsImidazolesCapillary PermeabilityPhantoms, ImagingIndazolesImage Interpretation, Computer-AssistedContrast MediaNeoadjuvant TherapyNeovascularization, Pathologic

• Abstract P6-01-33: Diffusion-weighted magnetic resonance imaging for subtype-specific prediction of pathologic complete response in neoadjuvant chemotherapy.
  Cancer Research 2023 Judith Zimmermann, Julia Carmona-Bozo, Nu N. Le, Natsuko Onishi, Lisa J. Wilmes, Jessica E. Gibbs, Jiachao Liang, David C. Newitt, Savannah Partridge, Patrick Bolan, Bonnie N. Joe, Elissa R. Price, …
• Abstract PD16-07: Association of MRI morphologic phenotype from unsupervised learning with breast cancer subtypes and treatment response.
  Cancer Research 2023 Nu N. Le, Natsuko Onishi, David C. Newitt, Jessica E. Gibbs, Lisa J. Wilmes, Efstathios Gennatas, Barbara LeStage, Laura J. Esserman, Nola M. Hylton, Wen Li
• Chapter 14 Multiplatform Standardization of Breast DWI Protocols: Quality Control and Test Objects.
  2023 Dariya Malyarenko, Lisa J. Wilmes, Thomas L. Chenevert
• Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.
  Cancers 2022 Li W, Le NN, Onishi N, Newitt DC, Wilmes LJ, Gibbs JE, Carmona-Bozo J, Liang J, Partridge SC, Price ER, Joe BN, Kornak J, Magbanua MJM, Nanda R, LeStage B, Esserman LJ, Van't Veer LJ, Hylton NM
• Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer.
  Tomography (Ann Arbor, Mich.) 2022 Le NN, Li W, Onishi N, Newitt DC, Gibbs JE, Wilmes LJ, Kornak J, Partridge SC, LeStage B, Price ER, Joe BN, Esserman LJ, Hylton NM

Show all (44 more) Hide

• Abstract P3-03-02: Diffusion-weighted MRI for prediction of pathologic complete response in HER2- breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy.
  Cancer Research 2022 Wen Li, Nu N Le, Natsuko Onishi, David C Newitt, Jessica E Gibbs, Lisa J Wilmes, John Kornak, Savannah C Partridge, Barbara LeStage, Elissa R Price, Bonnie N Joe, Laura J Esserman, Nola M Hylton
• Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting Bias.
  Tomography (Ann Arbor, Mich.) 2022 Pang Y, Malyarenko DI, Wilmes LJ, Devaraj A, Tan ET, Marinelli L, Endt AV, Peeters J, Jacobs MA, Newitt DC, Chenevert TL
• Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
  Radiology 2021 Onishi N, Li W, Newitt DC, Harnish RJ, Strand F, Nguyen AA, Arasu VA, Gibbs J, Jones EF, Wilmes LJ, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard S, Umphrey HR, Nelson …
• Abstract PD6-05: Subtype-specific MRI models to guide selection of candidates for de-escalation of neoadjuvant therapy.
  Cancer Research 2021 Wen Li, David C Newitt, Jessica Gibbs, Lisa J Wilmes, Ella F Jones, Natsuko Onishi, Bonnie N Joe, Elissa Price, John Kornak, Christina Yau, Denise M Wolf, Barbara LeStage, Susan Samson, Laura J …
• Abstract PS11-08: Operational standardization and quality assurance yield high acceptance rate for breast MRI in the I-SPY 2 TRIAL.
  Cancer Research 2021 Jessica Gibbs, David C Newitt, Margarita Watkins, Wen Li, Lisa Cimino, Clifton Li, Natsuko Onishi, Lisa J Wilmes, Teffany Joy Bareng, Evelyn Proctor, Barbara LeStage, Bev Parker, Nola M Hylton
• Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702).
  Journal of breast imaging 2020 Whisenant JG, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, McDonald ES, …
• Denoising and Multiple Tissue Compartment Visualization of Multi-b-Valued Breast Diffusion MRI.
  Journal of Magnetic Resonance Imaging 2020 Ek T. Tan, Lisa J. Wilmes, Bonnie N. Joe, Natsuko Onishi, Vignesh A. Arasu, Nola M. Hylton, Luca Marinelli, David C. Newitt
• Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL.
  NPJ breast cancer 2020 Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, Strand F, Onishi N, Nguyen AA, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard SA, Umphrey H, Bernreuter W, …
• Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
  Radiology 2020 McDonald ES, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Whisenant JG, Yankeelov TE, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, …
• Denoising and Multiple Tissue Compartment Visualization of Multi-b-Valued Breast Diffusion MRI.
  Journal of magnetic resonance imaging : JMRI 2020 Tan ET, Wilmes LJ, Joe BN, Onishi N, Arasu VA, Hylton NM, Marinelli L, Newitt DC
• Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.
  Tomography (Ann Arbor, Mich.) 2020 Onishi N, Li W, Gibbs J, Wilmes LJ, Nguyen A, Jones EF, Arasu V, Kornak J, Joe BN, Esserman LJ, Newitt DC, Hylton NM
• Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility Study.
  Tomography (Ann Arbor, Mich.) 2020 Malyarenko DI, Newitt DC, Amouzandeh G, Wilmes LJ, Tan ET, Marinelli L, Devaraj A, Peeters JM, Giri S, Vom Endt A, Hylton NM, Partridge SC, Chenevert TL
• Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer.
  Tomography (Ann Arbor, Mich.) 2020 Li W, Newitt DC, Yun B, Jones EF, Arasu V, Wilmes LJ, Gibbs J, Nguyen AA, Onishi N, Kornak J, Joe BN, Esserman LJ, Hylton NM
• Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges.
  Journal of magnetic resonance imaging : JMRI 2019 Greenwood HI, Wilmes LJ, Kelil T, Joe BN
• Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
  Journal of magnetic resonance imaging : JMRI 2019 Li W, Newitt DC, Wilmes LJ, Jones EF, Arasu V, Gibbs J, La Yun B, Li E, Partridge SC, Kornak J, I-SPY 2 Consortium, Esserman LJ, Hylton NM
• Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs.
  Journal of magnetic resonance imaging : JMRI 2019 Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, Mukherjee P, Nordstrom RJ, Peskin AP, …
• Abstract P2-09-23: Diffusion-weighted MRI improves imaging prediction of response in the I-SPY 2 trial.
  Poster Session Abstracts 2018 W Li, LJ Wilmes, DC Newitt, EF Jones, J Gibbs, M Poon, E Li, SC Partridge, J Kornak, LJ Esserman, NM Hylton
• Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study.
  Magnetic resonance in medicine 2017 Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, …
• Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
  Breast cancer research : BCR 2017 Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, …
• Abstract PD3-05: Effect of MR imaging contrast kinetic thresholds for prediction of neoadjuvant chemotherapy response in breast cancer subtypes – Results from ACRIN 6657 / I-SPY 1 trial.
  Poster Discussion Abstracts 2017 W Li, V Arasu, EF Jones, DC Newitt, LJ Wilmes, J Kornak, LJ Esserman, NM Hylton
• Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
  Tomography (Ann Arbor, Mich.) 2016 Wilmes LJ, Li W, Shin HJ, Newitt DC, Proctor E, Harnish R, Hylton NM
• Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL.
  Tomography (Ann Arbor, Mich.) 2016 Li W, Arasu V, Newitt DC, Jones EF, Wilmes L, Gibbs J, Kornak J, Joe BN, Esserman LJ, Hylton NM, ACRIN 6657 Trial Team and I-SPY Investigators Network
• QIN DAWG Validation of Gradient Nonlinearity Bias Correction Workflow for Quantitative Diffusion-Weighted Imaging in Multicenter Trials.
  Tomography (Ann Arbor, Mich.) 2016 Malyarenko DI, Wilmes LJ, Arlinghaus LR, Jacobs MA, Huang W, Helmer KG, Taouli B, Yankeelov TE, Newitt D, Chenevert TL
• Variability and bias assessment in breast ADC measurement across multiple systems.
  Journal of magnetic resonance imaging : JMRI 2016 Keenan KE, Peskin AP, Wilmes LJ, Aliu SO, Jones EF, Li W, Kornak J, Newitt DC, Hylton NM
• Design of a breast phantom for quantitative MRI.
  Journal of magnetic resonance imaging : JMRI 2016 Keenan KE, Wilmes LJ, Aliu SO, Newitt DC, Jones EF, Boss MA, Stupic KF, Russek SE, Hylton NM
• Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.
  PloS one 2016 Lo WC, Li W, Jones EF, Newitt DC, Kornak J, Wilmes LJ, Esserman LJ, Hylton NM
• Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumors.
  Drug Metabolism, Transport, and Biodistribution 2015 Imke H. Bartelink, Brendan Prideaux, Gregor Krings, Lisa Wilmes, Pei R.E. Lee, Byron Hann, Jean-Philippe Coppé, Diane Heditsian, Lamorna Swigart-Brown, Ella F. Jones, Sergey Magnitsky, Ron Keizer, …
• Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the american college of radiology imaging network 6698 breast cancer trial.
  Journal of magnetic resonance imaging : JMRI 2015 Newitt DC, Tan ET, Wilmes LJ, Chenevert TL, Kornak J, Marinelli L, Hylton N
• Repeatability of quantitative MRI measurements in normal breast tissue.
  Translational oncology 2014 Aliu SO, Jones EF, Azziz A, Kornak J, Wilmes LJ, Newitt DC, Suzuki SA, Klifa C, Gibbs J, Proctor EC, Joe BN, Hylton NM
• High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging.
  Journal of magnetic resonance imaging : JMRI 2013 McLaughlin RL, Newitt DC, Wilmes LJ, Jones EF, Wisner DJ, Kornak J, Proctor E, Joe BN, Hylton NM
• High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.
  Academic radiology 2013 Wilmes LJ, McLaughlin RL, Newitt DC, Singer L, Sinha SP, Proctor E, Wisner DJ, Saritas EU, Kornak J, Shankaranarayanan A, Banerjee S, Jones EF, Joe BN, Hylton NM
• High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer.
  Academic radiology 2011 Singer L, Wilmes LJ, Saritas EU, Shankaranarayanan A, Proctor E, Wisner DJ, Chang B, Joe BN, Nishimura DG, Hylton NM
• P2-08-06: Improved Spatial Resolution Diffusion-Weighted Imaging for Characterizing Tumors and Treatment Response in Patients with Invasive Breast Cancer.
  Poster Session Abstracts 2011 LJ Wilmes, R McLaughlin, S Sinha, L Singer, E Proctor, D Wisner, DN Newitt, A Shankaranarayanan, BN Joe, NM Hylton
• P2-09-12: High Resolution Diffusion MRI Characterizes Tumor Stromal Boundaries.
  Poster Session Abstracts 2011 RL McLaughlin, DC Newitt, LJ Wilmes, S Sinha, DJ Wisner, NM Hylton
• Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements.
  Magnetic resonance imaging 2011 Partridge SC, Singer L, Sun R, Wilmes LJ, Klifa CS, Lehman CD, Hylton NM
• Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model.
  Magnetic resonance in medicine 2011 Liu S, Shah SJ, Wilmes LJ, Feiner J, Kodibagkar VD, Wendland MF, Mason RP, Hylton N, Hopf HW, Rollins MD
• Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort.
  Magnetic resonance imaging 2009 Klifa C, Carballido-Gamio J, Wilmes L, Laprie A, Shepherd J, Gibbs J, Fan B, Noworolski S, Hylton N
• Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
  Journal of magnetic resonance imaging : JMRI 2007 Moasser MM, Wilmes LJ, Wong CH, Aliu S, Li KL, Wang D, Hom YK, Hann B, Hylton NM
• Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging.
  Magnetic resonance in medicine 2007 Li KL, Henry RG, Wilmes LJ, Gibbs J, Zhu X, Lu Y, Hylton NM
• Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.
  Developmental Dynamics 2007 Mikala Egeblad, H.-C. Jennifer Shen, Danielle J. Behonick, Lisa Wilmes, Alexandra Eichten, Lidiya V. Korets, Farrah Kheradmand, Zena Werb, Lisa M. Coussens
• Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.
  Developmental dynamics : an official publication of the American Association of Anatomists 2007 Egeblad M, Shen HC, Behonick DJ, Wilmes L, Eichten A, Korets LV, Kheradmand F, Werb Z, Coussens LM
• AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
  Magnetic resonance imaging 2007 Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM
• Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging.
  Journal of magnetic resonance imaging : JMRI 2007 Klifa CS, Shimakawa A, Siraj Z, Gibbs JE, Wilmes LJ, Partridge SC, Proctor E, Hylton NM
• Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
  Journal of magnetic resonance imaging : JMRI 2005 Li KL, Wilmes LJ, Henry RG, Pallavicini MG, Park JW, Hu-Lowe DD, McShane TM, Shalinsky DR, Fu YJ, Brasch RC, Hylton NM